Concepedia

Robin DeWalt

RD

Statistics

Publications

1

Citations

11

H-Index

1

Active since

2019

Affiliations

Eli Lilly (United States)(Current)

Robin DeWalt is an author at Eli Lilly (United States) specializing in tumor-associated enzyme targeting, allosteric binding, and differentiation.

Publications per year

2019–2019

1

Publications

1

Abstract LB-274: Identification and characterization of LY3410738, a novel covalent inhibitor of cancer-associated mutant Isocitrate Dehydrogenase 1 (IDH1)

Nathan A. Brooks, Robin DeWalt, Serge L. Boulet et al. · Cancer Research · 2019 · 11 citations

, , +14

1–1 of 1